Mice with liver-specific inactivation of Blnc1 were resistant to HFD-induced hepatic steatosis and had lower plasma TAG levels, metabolic changes characteristic of diminished hepatic lipogenesis. The gene discussed is PAQR9; the disease is Hepatic steatosis.